Cargando…

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy

The efficacy of traditional chemotherapy often suffers from rapid clearance and off-target toxicity. Drug delivery systems and controlled release are applied to improve the therapeutic efficiencies of small-molecule drugs. In this work, two novel oxidative/reductive (Ox/Re) -sensitive and one non-se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jincheng, Lv, Qingzhi, Wei, Wei, Yang, Zhengtao, Dong, Jiajun, Zhang, Ruoshi, Kan, Qiming, He, Zhonggui, Xu, Youjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058529/ https://www.ncbi.nlm.nih.gov/pubmed/29553858 http://dx.doi.org/10.1080/10717544.2018.1451935

Ejemplares similares

Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
por: Ma, Xianbin, et al.
Publicado: (2022)

Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
por: Lou, Xinyu, et al.
Publicado: (2021)

A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
por: Sun, Yixin, et al.
Publicado: (2019)

Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy
por: Liang, Yuanwei, et al.
Publicado: (2018)

Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy
por: Moret, Francesca, et al.
Publicado: (2021)

Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
por: Yu, Jiang, et al.
Publicado: (2020)

Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016)

Polydopamine-modified ROS-responsive prodrug nanoplatform with enhanced stability for precise treatment of breast cancer
por: Yang, Bin, et al.
Publicado: (2019)

Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies
por: Wang, Xin, et al.
Publicado: (2021)

Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections
por: Cheng, Liting, et al.
Publicado: (2021)

Bioresponsive matrices in drug delivery
por: You, Jin-Oh, et al.
Publicado: (2010)

Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems
por: Wang, Junqing, et al.
Publicado: (2017)

Recent advances of bioresponsive polymeric nanomedicine for cancer therapy
por: Hong, Tu, et al.
Publicado: (2022)

Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy
por: Zhang, Shenwu, et al.
Publicado: (2021)

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
por: Sun, Bingjun, et al.
Publicado: (2019)

Bioresponsive Polymers for Nanomedicine—Expectations and Reality!
por: Quader, Sabina, et al.
Publicado: (2022)

A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy
por: Shan, Lingling, et al.
Publicado: (2018)

Editorial: Bioresponsive nanomaterials for drug delivery or controlled release
por: Pan, Yan, et al.
Publicado: (2023)

Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis
por: Yang, Fang, et al.
Publicado: (2017)

Guanidinylated bioresponsive poly(amido amine)s designed for intranuclear gene delivery
por: Yu, Jiankun, et al.
Publicado: (2016)

Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly
por: Fu, Q., et al.
Publicado: (2015)

Bioresponsive and near infrared photon co-enhanced cancer theranostic based on upconversion nanocapsules
por: Xu, Jiating, et al.
Publicado: (2018)

Designing bioresponsive nanomaterials for intracellular self-assembly
por: Chagri, Sarah, et al.
Publicado: (2022)

Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer Therapy
por: Cheng, Zhiyang, et al.
Publicado: (2021)

Implantable Bioresponsive Hydrogel Prevents Local Recurrence of Breast Cancer by Enhancing Radiosensitivity
por: Fu, Zhiguang, et al.
Publicado: (2022)

Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
por: Singh, Neetu, et al.
Publicado: (2011)

Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition
por: Purcell, Brendan P., et al.
Publicado: (2014)

Bioresponsive Hydrogels: Chemical Strategies and Perspectives in Tissue Engineering
por: Sgambato, Antonella, et al.
Publicado: (2016)

Microenvironment Stimulated Bioresponsive Small Molecule Carriers for Radiopharmaceuticals
por: Chaturvedi, Shubhra, et al.
Publicado: (2020)

Bioresponsive drug delivery systems for the treatment of inflammatory diseases
por: Dou, Yin, et al.
Publicado: (2020)

Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
por: Mao, Yuqiang, et al.
Publicado: (2020)

Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy
por: Li, Yaqiao, et al.
Publicado: (2022)

Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy
por: Zhang, Shenwu, et al.
Publicado: (2017)

Intracellular distribution and internalization pathways of guanidinylated bioresponsive poly(amido amine)s in gene delivery()
por: Zhang, Jinmin, et al.
Publicado: (2018)

Novel guanidinylated bioresponsive poly(amidoamine)s designed for short hairpin RNA delivery
por: Yu, Jiankun, et al.
Publicado: (2016)

Correction: Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy
por: Tang, Dongyang, et al.
Publicado: (2020)

Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy
por: Jiang, Yanhua, et al.
Publicado: (2020)

Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy
por: Li, Yanan, et al.
Publicado: (2021)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy
por: Zeng, Zeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8205lj5piikr5s4dcag6bi4v4